Literature DB >> 33911427

Neurofibroma of External Ear: The Updates.

Neha Shakrawal1.   

Abstract

Entities:  

Year:  2020        PMID: 33911427      PMCID: PMC8061654          DOI: 10.4103/JCAS.JCAS_74_20

Source DB:  PubMed          Journal:  J Cutan Aesthet Surg        ISSN: 0974-2077


× No keyword cloud information.
Dear Editor, I would like to resubmit this article for the kind consideration for publication in your esteemed journal. I am happy to inform you that I have thoroughly gone through the literature to address the issues raised by the reviewers with evidences. I give a point wise reply to the reviewers’ comments. Which histopathologic variant is common among external ear neurofibroma (NF)? Of three histopathological types, that is, localized, plexiform, and diffuse;[1] diffuse variant involves skin and subcutaneous tissues of head neck region.[23456 Among head neck region, periauricular area is the most common site.[1] So diffuse variant is common among external ear NF. How long the patients need follow-up? Follow-up is mainly to identify an early recurrence in operated cases. If we are planning observation only, wait and watch at regular intervals with radiological evaluation and radical excision if there is an evidence of tumor growth.[7] As we know that diffuse NFs recur frequently.[8] Follow-up should depend on the age of the patient, extent and location of tumor, and partial or complete excision status. We can expect a less recurrence and hence increase the follow-up duration when there is a gross total resection and low residual tumor volume.[9] Proper counseling regarding early follow-up is needed, if there is rapidly enlarging mass, neurogenic pain/motor weakness, or disfiguring.[10] Literature does not mention the exact duration for follow-up. van Zuuren and Posma[2] advised yearly follow-up in their article. Is magnetic resonance imaging (MRI) necessary in all these patients? Imaging is done to know the characteristic, extent, and deeper extension of a soft tissue lesion. Although NFs are superficial lesions, which can be evaluated clinically, but it is always better to carry out radiology before histopathological confirmation. Ultrasonography (USG) and computed tomography (CT) can assess the nature but cannot demarcate between the vascularity of the lesion. USG has the advantages of no radiation exposure, cost-effectiveness, and early reports; it also carries limitations of not assessing the extent and depth of larger lesions. CT can help to know the extent when bony external auditory canal starts getting involved. MRI is the investigation of choice as it demarcates the tumor with the surrounding structures; it also differentiates between all three varieties, that is, local, plexiform, and diffuse. USG and CT scans are less reliable as diffuse NF resembles lipoma or hemangioma.[11] If MRI suggests a highly vascular lesion, consider a preoperative angiogram, and if necessary, a preoperative intra-arterial embolization, if hemorrhage is anticipated.[12] Therefore, in resourceful settings, we should consider MRI as a necessary investigation in these patients. What are the long-term complications of surgery in these patients? The long-term complications of surgery are recurrence, hypertrophic scarring,[13] permanent neurological deficit, functional impairment, wound healing abnormalities,[1415] and rarely malignant transformation.[1617] Age <10 years at surgery, head-neck-face-trunk lesion, and incomplete resection take shorter relapse time.[918] Several authors advised for wide meatoplasty to prevent reobstruction.[19] We have a case that reports wide external auditory canal after 5.5-year follow-up.[20] Therefore, the major concerns to be kept in mind during surgery are the extent of resection in balance to the likelihood of recurrence and loss of function.

REVIEWERS’ COMMENTS

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  16 in total

1.  M-meatoplasty: results and patient satisfaction in 125 patients (199 ears).

Authors:  J Rombout; P M van Rijn
Journal:  Otol Neurotol       Date:  2001-07       Impact factor: 2.311

2.  Diffuse neurofibroma of the orbit associated with temporal meningocele and neurofibromatosis-1.

Authors:  S B Kapadia; I P Janecka; H D Curtin; B L Johnson
Journal:  Otolaryngol Head Neck Surg       Date:  1998-12       Impact factor: 3.497

3.  Neural sheath tumors of major nerves.

Authors:  T R Donner; R M Voorhies; D G Kline
Journal:  J Neurosurg       Date:  1994-09       Impact factor: 5.115

4.  Neurofibromatosis in childhood.

Authors:  N L Fienman; W C Yakovac
Journal:  J Pediatr       Date:  1970-03       Impact factor: 4.406

5.  Resection of plexiform neurofibromas in children with neurofibromatosis type 1.

Authors:  Federico Canavese; Joseph I Krajbich
Journal:  J Pediatr Orthop       Date:  2011 Apr-May       Impact factor: 2.324

6.  Subcutaneous diffuse neurofibroma of the neck: a case report.

Authors:  S J de Varebeke; A De Schepper; E Hauben; F Declau; E Van Marck; P H Van de Heyning
Journal:  J Laryngol Otol       Date:  1996-02       Impact factor: 1.469

7.  Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1.

Authors:  Carlos E Prada; Fatima A Rangwala; Lisa J Martin; Anne M Lovell; Howard M Saal; Elizabeth K Schorry; Robert J Hopkin
Journal:  J Pediatr       Date:  2011-10-11       Impact factor: 4.406

8.  Imaging appearance of diffuse neurofibroma.

Authors:  Douglass S Hassell; Laura W Bancroft; Mark J Kransdorf; Jeffrey J Peterson; Thomas H Berquist; Mark D Murphey; Julie C Fanburg-Smith
Journal:  AJR Am J Roentgenol       Date:  2008-03       Impact factor: 3.959

9.  Neurofibroma of the ear: function and aesthetics.

Authors:  T P Trevisani; A L Pohl; H S Matloub
Journal:  Plast Reconstr Surg       Date:  1982-08       Impact factor: 4.730

10.  Histopathological variants of neurofibroma. A study of 114 lesions.

Authors:  M Megahed
Journal:  Am J Dermatopathol       Date:  1994-10       Impact factor: 1.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.